JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shoup, T. M.
Right arrow Articles by Fischman, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shoup, T. M.
Right arrow Articles by Fischman, A. J.
Journal of Nuclear Medicine Vol. 46 No. 2 297-304
© 2005 by Society of Nuclear Medicine


Basic Science Investigations

Evaluation of trans-9-18F-Fluoro-3,4-Methyleneheptadecanoic Acid as a PET Tracer for Myocardial Fatty Acid Imaging

Timothy M. Shoup, PhD, David R. Elmaleh, PhD, Ali A. Bonab, PhD and Alan J. Fischman, MD, PhD

Division of Nuclear Medicine, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts

This study describes the radiosynthesis and preliminary biologic evaluation of trans-9(RS)-18F-fluoro-3,4(RS,RS)-methyleneheptadecanoic acid (18F-FCPHA) as a new potential probe for assessing myocardial fatty acid metabolism by PET. This fatty acid, containing a cyclopropyl moiety in the ß,{gamma}-position, was designed to enter the myocardium by the same mechanism as natural fatty acids and to undergo partial metabolism before being trapped in the cell. Methods: 18F-FCPHA and the ß-methyl analog 8(RS)-18F-fluoro-3(RS)-methylheptadecanoic acid (18F-FBMHA) were prepared from their corresponding mesylate precursors by nucleophilic substitution. The precursors used for labeling were fully characterized, and the data were consistent with the proposed structures. Biodistribution studies of each tracer were performed with Sprague-Dawley rats at 5 and 60 min after injection. Sequential imaging of a rhesus monkey injected with 222 MBq of 18F-FCPHA was performed by use of a microPET camera. Results: At 5 and 60 min, heart uptake values measured as mean ± SD percentage injected dose per gram (%ID/g) in rats for 18F-FCPHA were 1.55 ± 0.72 and 1.43 ± 0.14, respectively. The heart-to-blood ratios at 5 and 60 min, an indication of target definition, were 25.8 and 20.4, respectively. The heart-to-lung ratios at 5 and 60 min were 3.3 and 4.6, respectively. Bone accumulation (%ID/g), an indication of defluorination, was 0.16 ± 0.03 at 5 min and increased to 0.70 ± 0.39 at 60 min. The heart-to-blood ratio obtained with 18F-FBMHA was 2.6 at 5 min and did not change significantly at 60 min. Imaging of the monkey heart after injection of 18F-FCPHA showed an initial spike of activity corresponding to blood flow followed by a plateau at 10 min. Conclusion: The cyclopropyl moiety in 18F-FCPHA does have a significant influence on heart accumulation, as suggested by the high heart-to-blood ratio and the fast blood clearance in rats. These results, along with the remarkable quality of the PET images, indicate the potential of this new class of labeled fatty acids for use in studying heart disease by PET.

Key Words: 18F fatty acid • PET • myocardial fatty acid imaging


Related articles in JNM:

THIS MONTH IN JNM

JNM 2005 46: 8a-9a. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.